AURELIO-04: A PHASE 2, OPEN-LABEL, SINGLE-ARM, MULTICENTER STUDY TO DETERMINE THE EFFICACY AND SAFETY OF SOT101 IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH SELECTED ADVANCED SOLID TUMORS

被引：1
|
作者：
Champiat, Stephane [1 ]
Marabelle, Aurelien [1 ]
Davar, Diwakar [2 ]
Grell, Peter [3 ]
Ouali, Kaissa [1 ]
Patrikidou, Anna [1 ]
Schoenenberger, Andreu [4 ]
Jelinkova, Lenka Palova [4 ]
Adkins, Irena [4 ]
Tillmanns, Sascha [5 ]
Kiemle-Kallee, Joachim [5 ]
Sachse, Richard [5 ]
Garralda, Elena [6 ]
机构：
[1] Gustave Roussy, Villejuif, France
[2] Univ Pittsburgh, Pittsburgh, PA USA
[3] Masaryk Mem Canc Inst, Brno, Czech Republic
[4] SOTIO Biotech AS, Prague, Czech Republic
[5] SOTIO Biotech AG, Basel, Switzerland
[6] Vall dHebron Inst Oncol, Barcelona, Spain
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-SITC2022.0716
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
716
引用
收藏
页码：A749 / A749
页数：1
相关论文
共 50 条
  • [21] An open-label phase 1 trial of lenvatinib plus pembrolizumab in patients with advanced selected solid tumors
    Kitano, Shigehisa
    Fujiwara, Yutaka
    Shimizu, Toshio
    Iwasa, Satoru
    Yonemori, Kan
    Kondo, Shunsuke
    Shimomura, Akihiko
    Koyama, Takafumi
    Ebata, Takahiro
    Iizumi, Sakura
    Ikezawa, Hiroki
    Namiki, Masayuki
    Kubota, Tomoki
    Miura, Takuma
    Yamamoto, Noboru
    ANNALS OF ONCOLOGY, 2018, 29
  • [22] Phase 2 open-label study of pembrolizumab plus lenvatinib and belzutifan in patients with advanced solid tumors
    Kelley, Robin Kate
    Van Cutsem, Eric
    Lee, Michael S.
    Wolf, Ido
    Fakih, Marwan
    de Vos-Geelen, Judith
    Lee, Valerie
    Vogel, Arndt
    Wu, Xi Lawrence
    Jin, Fan
    Naik, Girish S.
    O'Reilly, Eileen Mary
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [23] Safety and efficacy of elapegademase in patients with adenosine deaminase deficiency: A multicenter, open-label, single-arm, phase 3, and postmarketing clinical study
    Onodera, Masafumi
    Uchiyama, Toru
    Ariga, Tadashi
    Yamada, Masafumi
    Miyamura, Takako
    Arizono, Hironori
    Morio, Tomohiro
    IMMUNITY INFLAMMATION AND DISEASE, 2023, 11 (07)
  • [24] An open-label, multicenter, phase I study of RP2 as a single agent and in combination with nivolumab in patients with solid tumors: Safety, efficacy, and biomarker results
    Harrington, K. J.
    Sacco, J. J.
    Olsson-Brown, A.
    Chan, T.
    Nenclares, P.
    Leslie, I.
    Bommareddy, P.
    Ahlers, C.
    Wolff, J.
    Middleton, M. R.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S926 - S927
  • [25] Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical Trial
    Ali A. Mokdad
    Hao Zhu
    Muhammad S. Beg
    Yull Arriaga
    Jonathan E. Dowell
    Amit G. Singal
    Adam C. Yopp
    Targeted Oncology, 2019, 14 : 541 - 550
  • [26] Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical Trial
    Mokdad, Ali A.
    Zhu, Hao
    Beg, Muhammad S.
    Arriaga, Yull
    Dowell, Jonathan E.
    Singal, Amit G.
    Yopp, Adam C.
    TARGETED ONCOLOGY, 2019, 14 (05) : 541 - 550
  • [27] EFFICACY AND SAFETY OF AVAPRITINIB IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS: INTERIM RESULTS FROM THE OPEN-LABEL, SINGLE-ARM, PHASE 2 PATHFINDER STUDY
    Vannucchi, A. M.
    DeAngelo, D. J.
    Reiter, A.
    Radia, D.
    Deininger, M. W.
    George, T. I.
    Panse, J.
    Jentzsch, M.
    Alvarez-Twose, I.
    Mital, A.
    Hermine, O.
    Dybedal, I.
    Hexner, E. O.
    Hicks, L. K.
    Span, L.
    Mesa, R.
    Bose, P.
    Pettit, K. M.
    Heaney, M. L.
    Oh, S.
    Sen, J.
    Lin, H-M.
    Mar, B. G.
    Gotlib, J.
    HAEMATOLOGICA, 2021, 106 (10) : 2 - 2
  • [28] Nintedanib for patients with lymphangioleiomyomatosis: a phase 2, open-label, single-arm study
    Harari, Sergio
    Elia, Davide
    Caminati, Antonella
    Geginat, Jens
    Luisi, Francesca
    Pelosi, Giuseppe
    Specchia, Claudia
    Torre, Olga
    Trevisan, Roberta
    Vasco, Chiara
    Zompatori, Maurizio
    Cassandro, Roberto
    LANCET RESPIRATORY MEDICINE, 2024, 12 (12): : 967 - 974
  • [29] Safety and Efficacy of Iguratimod in Patients with Active Rheumatoid Arthritis: A Multicenter, Single-Arm, Open-Label, Real World Study
    Mu, Rong
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [30] Efficacy and Safety of Ripretinib in Chinese Patients with Advanced Gastrointestinal Stromal Tumors as a Fourth- or Later-Line Therapy: A Multicenter, Single-Arm, Open-Label Phase II Study
    Li, Jian
    Cai, Shirong
    Zhou, Yongjian
    Zhang, Jun
    Zhou, Ye
    Cao, Hui
    Wu, Xin
    Deng, Yanhong
    Huang, Zhao
    Dong, Juan
    Shen, Lin
    CLINICAL CANCER RESEARCH, 2022, 28 (16) : 3425 - 3432
12345